We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,930.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 08th Jul 2013 08:48

Anglo American: Exane reduces target price from 1700p to 1400p and reiterates its underperform rating.Anite Group: Investec raises target price from 135p to 155p and upgrades from hold to buy.Ashmore Group: RBC Capital Markets takes target price from 440p to 375p and keeps its neutral rating.Balfour Beatty: Bank of America cuts target price from 255p to 240p and downgrades to neutral.Bovis Homes Group: Jefferies ups target price from 897p to 909p keeping a buy recommendation. Panmure Gordon raises target price from 660p to 714p and retains a hold recommendation.Escher Group: Panmure Gordon moves target price from 459p to 465p reiterating a buy recommendation.Fidessa: Sanlam Securities increases target price from 2000p to 2340p and stays with a buy recommendation.Hikma Pharmaceuticals: HSBC Holdings raises target price from 745p to 1035p, while retaining a neutral rating. Panmure Gordon takes target price from 1000p to 1100p and leaves its buy recommendation unaltered.Interserve: Westhouse Securities ups target price from 537p to 582p keeping an add rating.Investec: Morgan Stanley lowers target price from 525p to 500p and maintains an overweight rating.Petropavlovsk: Goldman Sachs revises target price from 106p to 76p and keeps its sell recommendation.Polymetal International: HSBC Holdings reduces target price from 1000p to 620p, while leaving its overweight rating unchanged. Goldman Sachs cuts target price from 800p to 340p downgrading from neutral to sell.Polyus Gold International: Goldman Sachs moves target price from 230p to 210p leaving its neutral rating unaltered.Restaurant Group: JP Morgan increases target price from 525p to 565p and reiterates an overweight rating.Spirent Communications: Goldman Sachs shifts target price from 164p to 160p, but leaves its buy recommendation unchanged.Synergy Health: Investec downgrades from buy to add with a target price of 1170p.Vodafone: Credit Suisse moves target price from 180p to 195p and retains an outperform rating.Young & Co's Brewery: JP Morgan takes target price from 840p to 910p and stays with its overweight rating.
More News
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more
3 Nov 2022 09:18

LONDON MARKET OPEN: BT results disappoint; pound falls on Fed outlook

(Alliance News) - Stock prices in London opened lower on Thursday, as the pound fell against a strengthening dollar, after the Federal Reserve indicated that US interest rates are likely to reach higher levels than previously thought.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.